Decade-Long watch begins on growth hormone Drug's Real-World safety
NCT ID NCT05718570
Summary
This study aims to monitor the long-term safety and effectiveness of Sogroya (somapacitan) in adults with growth hormone deficiency who are already receiving it as part of their normal medical care. Over 5 to 10 years, researchers will collect information on side effects, health changes, and patient well-being from about 400 participants. The study is observational, meaning it watches what happens during standard treatment without changing how the drug is given.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULT GROWTH HORMONE DEFICIENCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
APHM - HOPITAL DE LA CONCEPTION - Service d'endocrinologie
Marseille, 13005, France
-
APHP - LA PITIE SALPETRIERE - Service endrocrinologie et medecine de la reproduction
Paris, 75013, France
-
Advanced Rx Clinical Research
Westminster, California, 92683, United States
-
Anschutz Outpatient Pavilion
Aurora, Colorado, 80045, United States
-
Atlanta Diabetes Associates
Atlanta, Georgia, 30318, United States
-
Barrow Neurological Institute
Phoenix, Arizona, 85013, United States
-
Brigham & Women's Hospital
Boston, Massachusetts, 02115, United States
-
CHU LILLE - HOPITAL CLAUDE HURIEZ - Service d'endocrinologie et diabétologie
Lille, 59000, France
-
CHU REIMS - HOPITAL ROBERT DEBRE - Service Endocrinologie-Diabète-Nutrition
Reims, 51100, France
-
Consano Clinical Research, LLC
Shavano Park, Texas, 78231, United States
-
Cornell University
New York, New York, 10021, United States
-
Dr Soliman Fakeeh Hospital
Jeddah, 23323, Saudi Arabia
-
Dr. Sulaiman Al Habib Medical Group- Olaya
Riyadh, 11643, Saudi Arabia
-
EP Premier Medical Group PA
El Paso, Texas, 79935, United States
-
Endokrinologikum Frankfurt
Frankfurt am Main, 60596, Germany
-
Fukuoka University Chikushi Hospital_Endocrinology and Diabetes Mellitus
Chikushino-shi, Fukuoka, 818-8502, Japan
-
HCL - HOPITAL LOUIS PRADEL - Service d'endocrinologie
Bron, 69500, France
-
Johns Hopkins University
Baltimore, Maryland, 21287, United States
-
Kagoshima University Hospital_Neurosurgery
Kagoshima-shi, Kagoshima, 890-8520, Japan
-
Keck Medical Center of USC - Outpatient Clinic
Los Angeles, California, 90033, United States
-
King Fahad Medical City
Riyadh, 59046, Saudi Arabia
-
Kobe University Hospital_Diabetes and Endocrinology
Kobe-shi, Hyogo, 650-0017, Japan
-
LMU Klinikum Großhadern München - Med. Klinik
München, 80336, Germany
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Medicover MVZ Oldenburg
Oldenburg, 26122, Germany
-
Medicover Neuroendokrinologie MVZ
München, 81667, Germany
-
Medicover Neuroendokrinologie MVZ München
München, 81667, Germany
-
Medicover Oldenburg MVZ
Oldenburg, 26122, Germany
-
Metabolic Research Institute Inc
West Palm Beach, Florida, 33401, United States
-
My clinic
Jeddah, Saudi Arabia
-
NYU Langone Health
New York, New York, 10017, United States
-
Nippon Medical School Musashikosugi Hospital_Neurological Surgery
Kawasaki-shi, Kanagawa, 211-8533, Japan
-
Northern Nevada Endocrinology
Reno, Nevada, 89511, United States
-
Northwestern Medical Group
Chicago, Illinois, 60642, United States
-
Okayama University Hospital_General Medicine
Okayama-shi, Okayama, 700-8558, Japan
-
Oregon Health & Science University
Portland, Oregon, 97239, United States
-
Osaka City General Hospital_Endocrinology and Diabetes Mellitus
Osaka-shi, Osaka, 534-0021, Japan
-
Palm Research Center Inc-Vegas
Las Vegas, Nevada, 89148, United States
-
Physicians East Endocrinology
Greenville, North Carolina, 27834, United States
-
Puget Sound VA, University of Washington
Seattle, Washington, 98108-1597, United States
-
Revival Research Institute, LLC
Dallas, Texas, 75231, United States
-
St Lukes Physician Group
Center Valley, Pennsylvania, 18034, United States
-
Stanford Univ School of Med
Palo Alto, California, 94304, United States
-
Tufts Medical Center
Boston, Massachusetts, 02111, United States
-
UCLA Health
Los Angeles, California, 90095, United States
-
UKC Ljubljana, Endocrinology and Diabetes
Ljubljana, 1000, Slovenia
-
UNMC
Omaha, Nebraska, 68198, United States
-
UT Southwestern Medical Center-CRU
Dallas, Texas, 75390, United States
-
Uniklinik Aachen - Endokrinologie und Diabetologie
Aachen, 52074, Germany
-
University Of Washington_Seattle
Seattle, Washington, 98195-6165, United States
-
University of North Carolina
Chapel Hill, North Carolina, 27514, United States
-
Universitätsklinikum Halle - Innere Medizin III
Halle, 06120, Germany
-
Universitätsklinikum Würzburg - Zentrum für Innere Medizin (ZIM)
Würzburg, 97080, Germany
-
Universitätsmedizin der JGU Mainz - Endokrinologie und Stoffwechselerkrankungen
Mainz, 55131, Germany
-
Washington University
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.